A Whole Blood Molecular Signature for Acute Myocardial Infarction

Area of Science:

• Cardiovascular Medicine
• Molecular Biology
• Biomarker Discovery

Background:

• Chest pain is a common symptom requiring medical attention, often leading to acute myocardial infarction (AMI) diagnosis.
• Current diagnostic methods for AMI rely on detecting myocyte death, lacking biomarkers for predicting impending cardiac events.
• Circulating endothelial cells (CECs) offer potential insights into early cardiovascular disease processes.

Purpose of the Study:

• To identify a transcriptomic signature in whole blood, specifically from CECs, indicative of AMI.
• To establish a novel biomarker for early detection of cardiac events.
• To investigate the potential of CECs in understanding plaque rupture dynamics.

Main Methods:

• Microarray analysis of enriched CEC samples to identify candidate AMI-related genes.
• Quantitative PCR (qPCR) to verify gene detectability and predictive value in whole blood.
• Validation of the identified transcriptomic signature in an independent patient cohort.

Main Results:

• A distinct CEC-derived molecular signature was identified in whole blood.
• This signature demonstrated the ability to identify patients with AMI.
• The signature showed potential for predicting earlier stages of cardiac events.

Conclusions:

• A whole blood CEC-derived molecular signature can effectively identify patients with AMI.
• This signature provides a framework for potentially detecting impending cardiac events earlier.
• Integration with clinical history and other diagnostics may enhance early cardiac event detection.